ALFA Finder| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 11.8 | 10.6 | 13.0 |
| Other income | 0.1 | 0.1 | 0.1 |
| Total income | 11.9 | 10.7 | 13.1 |
| Profit before exceptional items & tax | 0.2 | -0.1 | -1.6 |
| Profit before tax | 0.2 | -0.1 | -1.6 |
| Net profit | 0.1 | -0.0 | -1.1 |
| Operating margin | 1.7% | -0.9% | -12.2% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Revenue, year on year | -9.20% |
|---|---|
| Operating profit, year on year | +105.90% |
| Operating profit, quarter on quarter | +150.00% |
NSE results filing, NSE: BANKA. Figures extracted from the filing.
Banka Bioloo Ltd: key numbers
- Share price
- ₹78.00
- Market cap
- ₹85.31 Cr
- Revenue (annual)
- ₹57.09 Cr
- Net profit (annual)
- ₹0.35 Cr
- P/E (TTM)
- 55.0×Sector 21.5×
- Promoter holding
- 52.02%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Banka Bioloo Ltd
All →Banka Bioloo Employee Stock Options
Banka BioLoo received NSE listing and trading approval for 5,000 equity shares allotted under its ESOP scheme. Dealings in the shares begin on November 16, 2026.
Banka Bioloo Investor Presentation: Key Takeaways
Q2 FY27 standalone total income ₹1,656L (+24.5% YoY) and PAT ₹41.6L versus prior-year loss. Consolidated Q2 income fell 9.2% and PAT was ₹13.1L. Order book ₹83.4 Cr.
Banka Bioloo Price Movement Clarification
Banka BioLoo responded to NSE's query on a significant price movement, stating the spurt was market-driven. The company says it has made all required disclosures and has no pending price-sensitive announcement.
Banka Bioloo Employee Stock Options
Banka BioLoo Limited has granted 2,000 stock options under its Employees Stock Option Plan 2023. The options are exercisable at face value of Rs.10 per share.
Banka Bioloo Investor Presentation: Key Takeaways
Banka Bio reported FY26 total income of ₹58.4 cr (+7.1% YoY) and a return to profitability with ₹0.39 cr PAT. Strategy focuses on converting Megaliter's asset-light contracted revenues into recurring cash flows.
Banka Bioloo Annual General Meeting
Banka BioLoo Limited conducted its 14th Annual General Meeting on September 17, 2026. The meeting covered routine business, including financial statement adoption and director re-appointment.